Carregant...

In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

Carbapenem-resistant bacteria represent a significant treatment challenge due to the lack of active antimicrobials available. MK-7655 is a novel β-lactamase inhibitor under clinical development. We investigated the combined killing activity of imipenem and MK-7655 against four imipenem-resistant bac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hirsch, Elizabeth B., Ledesma, Kimberly R., Chang, Kai-Tai, Schwartz, Michael S., Motyl, Mary R., Tam, Vincent H.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393460/
https://ncbi.nlm.nih.gov/pubmed/22526311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05927-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!